1. National Tuberculosis Reference Laboratory, Laboratory for Infectious Diseases and Perinatal Screening (LIS), Centre for Infectious Disease Control (CIB), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
2. Department of Medical Microbiology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands
3. National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
4. KNCV Tuberculosis Foundation, The Hague, The Netherlands
5. Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
6. Department of Virology, Centre for Infectious Disease Control (CIB), National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
7. Tuberculosis and M/XDR-TB Programme, Division of Communicable Diseases, Health Security and Environment, World Health Organization (WHO), Regional Office for Europe, Copenhagen, Denmark
8. INSERM U1019, Lille, France
9. CNRS UMR 8204, Lille, France
10. Institut Pasteur de Lille, Center for Infection and Immunity of Lille, Lille, France
11. Université Lille Nord de France, Lille, France
12. GenoScreen, Lille, France
13. Department of Pulmonary Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands